Analysis of T and B Cell Repertoire Changes in Response to Orencia® (abatacept) in Rheumatoid Arthritis
RecruitingOBSERVATIONAL
Enrollment
72
Participants
Timeline
Start Date
November 1, 2022
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Conditions
Rheumatoid Arthritis
Trial Locations (1)
10021
RECRUITING
Hospital for Special Surgery, New York
All Listed Sponsors
lead
Hospital for Special Surgery, New York
OTHER
NCT05782335 - Analysis of T and B Cell Repertoire Changes in Response to Orencia® (abatacept) in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter